Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma
Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 930-939
DOI: 10.1111/apt.70797 ↗At a glance
Validierungsstudie in Alimentary Pharmacology & Therapeutics, published online on 2026-06-18. Written by Ryan Yanzhe Lim and 11 co-authors. Institution: Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Machine Learning. Cited 4 times so far (Crossref); 33 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Prognostic models for hepatocellular carcinoma (HCC) may have limited accuracy. We aimed to construct and validate a novel prognostic model for HCC that incorporates biomarkers for liver function and tumour characteristics.
Methods
Consecutive participants ( n = 1102) with HCC from five international tertiary institutions in Asia and the U.S. comprised the derivation ( n = 627), internal validation ( n = 270) and external validation ( n = 205) cohorts. The Liver Cancer Risk predictioN (LCRN) Index was constructed using a gradient‐boosted decision tree model based on the Cox proportional hazards framework. The discriminative performance of the LCRN Index was evaluated using Harrell's concordance index (C‐index) and compared to the albumin bilirubin grade (ALBI), Barcelona Clinic for Liver Cancer (BCLC) staging and Cox regression model. Model calibration was assessed using the integrated Brier score and calibration plots.
Results
The median (IQR) age was 66.0 (58.0–73.0) years, median (IQR) body mass index was 23.9 (22.1–26.1) kg/m 2 and 77.2% were male. The LCRN Index comprised type 2 diabetes mellitus, ascites, hepatic encephalopathy, albumin, bilirubin, AFP and diameter of largest tumour nodule. In the external validation cohort, the LCRN Index (1‐year area under the receiver operating curve [AUC]: 0.79; 3‐year AUC: 0.77; 5‐year AUC: 0.75) was numerically higher than the ALBI grade and BCLC stage for prognosticating HCC. The LCRN Index demonstrated improved calibration compared to the ALBI grade and BCLC stage.
Conclusion
The LCRN index is a promising tool for prognosticating HCC. If further validated, these data may have potential clinical implications for the management of HCC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- National University of Singapore, Department of Biomedical Informatics, Yong Loo Lin School of Medicine, Singapore, Singapore.
- National University of Singapore, Department of Pathology, Yong Loo Lin School of Medicine, Singapore, Singapore.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
- Zhejiang-Germany Interdisciplinary Joint Laboratory of Hepatobiliary-Pancreatic Tumor and Bioengineering, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.
ORCID profiles: Gang Chen, Jie Li, Hirokazu Takahashi, Daniel Q Huang
Cite
APA
Lim, R. Y., Selvakumar, V., Syn, N., Chen, G., Li, J., Kyaw, Z. M., Zhou, J., Kim, B. K., Wijarnpreecha, K., Takahashi, H., Huang, D. Q., & Liver Cancer Research Network (2026). Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics, 64(7), 930-939. https://doi.org/10.1111/apt.70797
Vancouver
Lim RY, Selvakumar V, Syn N, Chen G, Li J, Kyaw ZM, et al. Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma. Alimentary Pharmacology & Therapeutics. 2026;64(7):930-939. doi:10.1111/apt.70797
BibTeX
@article{Lim2026,
author = {Lim, Ryan Yanzhe and Selvakumar, Vigneshwaran and Syn, Nicholas and Chen, Gang and Li, Jie and Kyaw, Zin Myint and Zhou, Juequn and Kim, Beom Kyung and Wijarnpreecha, Karn and Takahashi, Hirokazu and Huang, Daniel Q and Liver Cancer Research Network, Liver Cancer Research Network},
title = {Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {7},
pages = {930--939},
doi = {10.1111/apt.70797}
}
EUVIMED